Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (765)	3/27/1998 12:08:00 AM
From: StockDoc	Respond to of 887

> I will take my original position and sell for a tax loss.< This should work. StockDoc

To: seminole who wrote (765)	3/29/1998 1:36:00 AM
From: Bob Barels	Read Replies (3) \| Respond to of 887

Since you have asked me to use my Ph.D. to do my own research here is my recommendation: ETHCY. For more information and analysis, visit their thread. It is a controlled drug release company ( My Ph.D and all my publications are in this field) and I am very familiar with their work. It is mucher easier for these kind of companies to receive FDA approval since they are working with drugs that are already in the market and aim at the delivery method only. Their recent drop came as a result of the departure of Dr. Guy, CEO. However, during last week the stock is gaining ground. My target is $6-8 by August. IMO, that DEPO is finished so I would sell everything (I already did) and never bother with this loser again. I think Stock Doc is right with his post at the ADVH thread. I won't even bother talking with them at The Netherlands. **If your post was sarcastic (it is difficult to tell) please ignore mine. regards Bob